| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.03 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |